These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9832149)

  • 1. Traumatic brain injury increases beta-amyloid peptide 1-42 in cerebrospinal fluid.
    Raby CA; Morganti-Kossmann MC; Kossmann T; Stahel PF; Watson MD; Evans LM; Mehta PD; Spiegel K; Kuo YM; Roher AE; Emmerling MR
    J Neurochem; 1998 Dec; 71(6):2505-9. PubMed ID: 9832149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Traumatic brain injury elevates the Alzheimer's amyloid peptide A beta 42 in human CSF. A possible role for nerve cell injury.
    Emmerling MR; Morganti-Kossmann MC; Kossmann T; Stahel PF; Watson MD; Evans LM; Mehta PD; Spiegel K; Kuo YM; Roher AE; Raby CA
    Ann N Y Acad Sci; 2000 Apr; 903():118-22. PubMed ID: 10818496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid beta 1-42 and tau in cerebrospinal fluid after severe traumatic brain injury.
    Franz G; Beer R; Kampfl A; Engelhardt K; Schmutzhard E; Ulmer H; Deisenhammer F
    Neurology; 2003 May; 60(9):1457-61. PubMed ID: 12743231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marked increase of beta-amyloid(1-42) and amyloid precursor protein in ventricular cerebrospinal fluid after severe traumatic brain injury.
    Olsson A; Csajbok L; Ost M; Höglund K; Nylén K; Rosengren L; Nellgård B; Blennow K
    J Neurol; 2004 Jul; 251(7):870-6. PubMed ID: 15258792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CSF and plasma amyloid-β temporal profiles and relationships with neurological status and mortality after severe traumatic brain injury.
    Mondello S; Buki A; Barzo P; Randall J; Provuncher G; Hanlon D; Wilson D; Kobeissy F; Jeromin A
    Sci Rep; 2014 Oct; 4():6446. PubMed ID: 25300247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in cerebrospinal fluid apolipoprotein E and amyloid beta-protein after traumatic brain injury.
    Kay AD; Petzold A; Kerr M; Keir G; Thompson E; Nicoll JA
    J Neurotrauma; 2003 Oct; 20(10):943-52. PubMed ID: 14588111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homocysteine metabolism is associated with cerebrospinal fluid levels of soluble amyloid precursor protein and amyloid beta.
    Oikonomidi A; Lewczuk P; Kornhuber J; Smulders Y; Linnebank M; Semmler A; Popp J
    J Neurochem; 2016 Oct; 139(2):324-332. PubMed ID: 27507672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid biomarkers of β-amyloid metabolism and neuronal damage in epileptic seizures.
    Shahim P; Rejdak R; Ksiazek P; Blennow K; Zetterberg H; Mattsson N; Rejdak K
    Eur J Neurol; 2014 Mar; 21(3):486-91. PubMed ID: 24372994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble BACE-1 Activity and sAβPPβ Concentrations in Alzheimer's Disease and Age-Matched Healthy Control Cerebrospinal Fluid from the Alzheimer's Disease Neuroimaging Initiative-1 Baseline Cohort.
    Savage MJ; Holder DJ; Wu G; Kaplow J; Siuciak JA; Potter WZ;
    J Alzheimers Dis; 2015; 46(2):431-40. PubMed ID: 25790831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid beta 1-42 and tau in cerebrospinal fluid after severe traumatic brain injury.
    Blennow K; Nellgård B
    Neurology; 2004 Jan; 62(1):159; author reply 159-60. PubMed ID: 14718730
    [No Abstract]   [Full Text] [Related]  

  • 11. Cerebrospinal fluid tau and amyloid-β1-42 in patients with dementia.
    Skillbäck T; Farahmand BY; Rosén C; Mattsson N; Nägga K; Kilander L; Religa D; Wimo A; Winblad B; Schott JM; Blennow K; Eriksdotter M; Zetterberg H
    Brain; 2015 Sep; 138(Pt 9):2716-31. PubMed ID: 26133663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid levels of soluble amyloid precursor protein and β-amyloid 42 in patients with multiple sclerosis, neuromyelitis optica and clinically isolated syndrome.
    Mai W; Hu X; Lu Z; Peng F; Wang Y
    J Int Med Res; 2011; 39(6):2402-13. PubMed ID: 22289560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of β-amyloid oligomers as a predictor of neurological outcome after brain injury.
    Gatson JW; Warren V; Abdelfattah K; Wolf S; Hynan LS; Moore C; Diaz-Arrastia R; Minei JP; Madden C; Wigginton JG
    J Neurosurg; 2013 Jun; 118(6):1336-42. PubMed ID: 23540266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid levels of amyloid precursor protein and amyloid beta-peptide in Alzheimer's disease and major depression - inverse correlation with dementia severity.
    Hock C; Golombowski S; Müller-Spahn F; Naser W; Beyreuther K; Mönning U; Schenk D; Vigo-Pelfrey C; Bush AM; Moir R; Tanzi RE; Growdon JH; Nitsch RM
    Eur Neurol; 1998; 39(2):111-8. PubMed ID: 9520072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Young to Middle-Aged Dogs with High Amyloid-β Levels in Cerebrospinal Fluid are Impaired on Learning in Standard Cognition tests.
    Borghys H; Van Broeck B; Dhuyvetter D; Jacobs T; de Waepenaert K; Erkens T; Brooks M; Thevarkunnel S; Araujo JA
    J Alzheimers Dis; 2017; 56(2):763-774. PubMed ID: 28035921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An integrated multi-study analysis of intra-subject variability in cerebrospinal fluid amyloid-β concentrations collected by lumbar puncture and indwelling lumbar catheter.
    Lucey BP; Gonzales C; Das U; Li J; Siemers ER; Slemmon JR; Bateman RJ; Huang Y; Fox GB; Claassen JA; Slats D; Verbeek MM; Tong G; Soares H; Savage MJ; Kennedy M; Forman M; Sjögren M; Margolin R; Chen X; Farlow MR; Dean RA; Waring JF
    Alzheimers Res Ther; 2015; 7(1):53. PubMed ID: 26225140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged changes in amyloid-β metabolism after a severe traumatic brain injury.
    Bagnato S; Andriolo M; Boccagni C; Galardi G
    Neuroreport; 2017 Mar; 28(5):250-252. PubMed ID: 28178070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlations between soluble α/β forms of amyloid precursor protein and Aβ38, 40, and 42 in human cerebrospinal fluid.
    Gabelle A; Roche S; Gény C; Bennys K; Labauge P; Tholance Y; Quadrio I; Tiers L; Gor B; Chaulet C; Vighetto A; Croisile B; Krolak-Salmon P; Touchon J; Perret-Liaudet A; Lehmann S
    Brain Res; 2010 Oct; 1357():175-83. PubMed ID: 20713025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Method for the determination of the levels of beta-amyloid peptide in the CSF sampled from freely moving rats.
    El Mouedden M; Haseldonckx M; Mackie C; Meert T; Mercken M
    J Pharmacol Toxicol Methods; 2005; 52(2):229-33. PubMed ID: 16125620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid biomarkers of β-amyloid metabolism in multiple sclerosis.
    Augutis K; Axelsson M; Portelius E; Brinkmalm G; Andreasson U; Gustavsson MK; Malmeström C; Lycke J; Blennow K; Zetterberg H; Mattsson N
    Mult Scler; 2013 Apr; 19(5):543-52. PubMed ID: 23069872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.